ARIS MINING ANNOUNCES RESULTS OF 2025 ANNUAL GENERAL MEETING
VANCOUVER, BC, May 15, 2025 /CNW/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) reports voting results from its Annual General Meeting of shareholders (the Meeting) held earlier today.
AGM Voting Results
Shareholders holding 63,558,598 shares, being 36.85% of the outstanding shares of the Company, were represented virtually or by proxy at the Meeting. The voting results from the Meeting are as follows:
Election of Directors
The following directors were elected to the Company's Board:
Appointment of Auditors
KPMG LLP was appointed as the auditor of the Company for the 2025 fiscal year, with their remuneration to be set by the Board.
About Aris Mining
Founded in September 2022, Aris Mining was established with a vision to build a leading Latin America-focused gold mining company. Our strategy blends current production and cashflow generation with transformational growth driven by expansions of our operating assets, exploration and development projects. Aris Mining is listed on the TSX (ARIS) and the NYSE-A (ARMN) and is led by an experienced team with a track record of value creation, operational excellence, financial discipline and good corporate governance in the gold mining industry.
Aris Mining operates two underground gold mines in Colombia: the Segovia Operations and the Marmato Upper Mine, which together produced 210,955 ounces of gold in 2024. With expansions underway, Aris Mining is targeting an annual production rate of more than 500,000 ounces of gold following the ramp-up of the Segovia mill expansion, expected during the second half of 2025, and the new Marmato Mine, which is expected to start ramping up in H2 2026. In addition, Aris Mining operates the 51% owned Soto Norte joint venture, where studies are underway on a new, smaller scale development plan, with results expected by mid-2025. In Guyana, Aris Mining owns the Toroparu gold/copper project, where a new Preliminary Economic Assessment (PEA) has been commissioned.
Colombia is rich in high-grade gold deposits and Aris Mining is actively pursuing partnerships with the Country's dynamic small-scale mining sector. With these partnerships, we enable safe, legal, and environmentally responsible operations that benefit both local communities and the industry.
Aris Mining intends to pursue acquisitions and other growth opportunities to unlock value through scale and diversification.
Additional information on Aris Mining can be found at www.aris-mining.com, www.sedarplus.ca, and on www.sec.gov.
Cautionary Language
Forward-Looking Information
This news release contains "forward-looking information" or forward-looking statements" within the meaning of Canadian securities legislation. All statements included herein, other than statements of historical fact, including, without limitation, statements included in the "About Aris Mining" section of this news release are forward-looking. Generally, the forward-looking information and forward looking statements can be identified by the use of forward looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", "will continue" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". The material factors or assumptions used to develop forward looking information or statements are disclosed throughout this news release.
Forward looking information and forward looking statements, while based on management's best estimates and assumptions, are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Aris Mining to be materially different from those expressed or implied by such forward-looking information or forward looking statements, including but not limited to those factors discussed in the section entitled "Risk Factors" in Aris Mining's annual information form dated March 12, 2025 which is available on SEDAR+ at www.sedarplus.ca and in the Company's filings with the SEC at www.sec.gov.
Although Aris Mining has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information or statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information or statements. The Company has and continues to disclose in its Management's Discussion and Analysis and other publicly filed documents, changes to material factors or assumptions underlying the forward-looking information and forward-looking statements and to the validity of the information, in the period the changes occur. The forward-looking statements and forward-looking information are made as of the date hereof and Aris Mining disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements or forward-looking information contained herein to reflect future results. Accordingly, readers should not place undue reliance on forward-looking statements and information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Market Online
37 minutes ago
- The Market Online
Market Open: Investors retreat as Iran-Israel war escalates
TSX futures trended lower on Tuesday morning as the Iran-Israel war continues to degenerate, with hundreds of lives lost entering the fifth day of fighting, and more investors moving to the sidelines in wait for calmer markets. The Israeli military issued an evacuation warning on Monday affecting about 330,000 people in Tehran in an area including three major hospitals, as well as Iran's state TV station and police headquarters. Market Numbers (Futures) TSX: Down (0.2%) 26,515.47. TSXV: Up (0.59%), 725.38. DOW: Down (0.44%), 42,350. NASDAQ: Down (0.47%), 21,838.75. FTSE: Down (0.4%), 8,844.12. In the Headlines The Mali government has taken control of Barrick Mining's Loulo-Gounkoto gold complex for an initial period of six months in an ongoing dispute over unpaid taxes. The complex and its accompanying Kibali mine rank within the top 10 gold mines in the world, with Barrick being Africa's largest gold producer. A number of Barrick employees were arrested and remain in detention on account of the dispute. Meanwhile, Canadian prime minister Mark Carney and U.S. president Donald Trump have set the mutual goal of ending the Canada-U.S. trade war within the next 30 days, with talks scheduled for later this week. The agreement, reached on Monday at the ongoing G7 summit, will also include discussions on critical metals, border security and the gun and drug trades, according to a report from The Globe and Mail. US: Up (0.08%), US$0.7374. Euro: Up (0.03%), €0.6374. GBP: Up (0.13%), £0.5433. JPY: Up (0.01%), ¥106.64. Bitcoin: Down (1.07%), C$143,298.31. (Conversion to C$1) Commodities (Futures) Natural Gas: Up (2.17%), US$3.82. WTI: Up (0.06%), US$71.81. Gold: Up (0.06%), US$3,386.20. Copper: Down (0.031%), US$4.8191. To stay up-to-date from market open to close head to Join the discussion: Find out what everybody's saying about the global market open on Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Cision Canada
39 minutes ago
- Cision Canada
FSRA's new Fraud Reporting Service Rule approved by the Minister of Finance Français
TORONTO, /CNW/ - Fraud drives up the cost of auto insurance for everyone operating a vehicle. That's why Ontario's financial services regulator (FSRA) is taking a critical step to help combat the effects of auto insurance fraud, with its Fraud Reporting Service (FRS) Rule and Guidance. The Rule, which has now been approved by the Minister of Finance, applies to all automobile insurers in Ontario and will come into effect when the government proclaims the related changes to the Insurance Act into force. FSRA will work with the industry and the Ontario government to ensure auto insurers clearly understand the new expectations and are able to effectively implement the changes before the Rule and Guidance take effect. "This is an important step toward more effectively tracking and identifying auto insurance fraud" said Glen Padassery, Executive Vice President of Policy and Auto Insurance, FSRA. "Fraud drives up costs for drivers. By improving how fraud is tracked and reported, we're helping build accountability across the system to better protect consumers." Once effective, the FRS Rule will require auto insurers to provide specific auto insurance fraud information to FSRA. These insights will help to: Better determine the amount of auto insurance fraud in the province Identify and address fraud trends Establish a baseline to be able to track and reduce the amount of fraud in the future By identifying and addressing fraud, auto insurance rates could be reduced. FSRA continues to work on behalf of all stakeholders, including consumers, to ensure financial safety, fairness, and choice for everyone. Learn more at FOR MEDIA INQUIRIES: Ashley Legassic Sr. Media Relations and Digital Officer Financial Services Regulatory Authority C: 647-719-8426 Email: [email protected] SOURCE Financial Services Regulatory Authority of Ontario
Cision Canada
40 minutes ago
- Cision Canada
AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers
VANCOUVER, BC, June 17, 2025 /CNW/ -- Venture Capital continues to flow in bunches into the AI in healthcare sector, with AI companies capturing more than half of digital health funding in Q1. Investors are seeking novel opportunities that tap into this space, with private companies such as Ellipsis Health and Autonomize AI recently receiving $45M and $28M respectively for their innovations. For other investors seeking opportunities among publicly traded companies, there's been plenty of development to follow from innovators, including from Avant Technologies, Inc. (OTCQB: AVAI), IQVIA Holdings Inc. (NYSE: IQV), SoundHound AI, Inc. (NASDAQ: SOUN), RadNet, Inc. (NASDAQ: RDNT), and The Cigna Group (NYSE: CI). According to McKinsey's Global Institute, generative AI isn't just a buzzword — it could deliver between $60 and $110 billion in annual value just within pharma and medical products. Meanwhile, Statista now expects the broader AI healthcare market to explode from $11 billion today to a staggering $188 billion by 2030, reflecting a major shift in how technology is expected to transform patient care, diagnostics, and operational efficiency. For example, screenings for diabetic retinopathy are now live across Costa Rica, Nicaragua, and Panama after Avant Technologies, Inc. (OTCQB: AVAI) and joint-venture partner Ainnova Tech began rolling out free Vision AI scans inside Grupo Dökka's Fischel and La Bomba pharmacy chains. The quick, non-invasive test looks for early retinal changes that often appear before symptoms, then delivers secure results in minutes. By placing the service in retail pharmacies—and preparing a parallel launch in Mexico—the partners are moving care closer to patients while collecting real-world evidence that can guide wider commercialization. "As we begin similar initiatives in Mexico, our goal is to close the patient care loop with timely treatment, connecting every step of the journey," said Vinicio Vargas, CEO of Ainnova Tech and board member of Ai-nova Acquisition Corp. "We are integrating pharma, retail, ophthalmologists, and our technology into a unified experience, all driven by one incentive, the well-being of the diabetic patient." The live-patient campaign gives Avant a timely proof point as it works to bring Vision AI under one roof. Earlier this month the company signed a non-binding letter of intent to acquire 100% of Ainnova, unifying leadership, intellectual property, and data ahead of a scheduled FDA pre-submission meeting in July. Folding the joint venture into a single public entity would eliminate the current holding-company structure and streamline everything from regulatory filings to revenue recognition. Management believes the simplified cap table will resonate with investors and prospective partners alike. While the corporate lawyers handle due diligence, engineers are putting final touches on a low-cost, automated retinal camera designed to pair seamlessly with Vision AI. Traditional fundus cameras can cost tens of thousands of dollars and require skilled technicians. Avant's prototype is hands-free, feeds images directly into the cloud platform, and is expected to ship at a fraction of legacy pricing. If performance data match internal tests, primary-care clinics and resource-constrained health systems could screen large diabetic populations without adding specialist staff. Vision AI itself is also widening its clinical scope. A patented dementia-risk module —combining a five-minute blood assay with AI pattern recognition—remains in validation, while cardiovascular-risk analytics are progressing through pilot studies in Latin America. Each new indication plugs into the same software backbone, positioning Avant as a platform rather than a single-product story. Financially, the merger would roll all outstanding Ainnova equity into the publicly traded company, avoiding cash dilution and aligning incentives for the combined team. Leadership has signaled that post-deal capital raises, if needed, would be targeted toward finishing the camera, scaling pharmacy deployments, and supporting U.S. regulatory work. Taken together, the live pharmacy screenings, pending acquisition, and upcoming device launch mark a pivotal stretch for Avant. The company is evolving from an AI incubator into a full-stack diagnostics firm with proprietary hardware, a growing menu of predictive algorithms, and on-the-ground distribution partners. If the strategy holds, Vision AI could shorten referral times, open earlier treatment windows, and give emerging-market providers affordable access to specialist-level insights—translating technology headlines into measurable patient impact. IQVIA Holdings Inc. (NYSE: IQV) has launched a new suite of AI agents tailored for the life sciences and healthcare sectors. "This is a pivotal opportunity to deliver the precise, efficient workflows and insights required by the modern life sciences industry," said Bhavik Patel, President of Commercial Solutions of IQVIA. "Our collaboration with NVIDIA helps us realize our vision to power smarter healthcare for everyone, everywhere." Built using NVIDIA's NIM Agent Blueprints and NeMo platforms, these agentic tools aim to accelerate research, streamline workflows, and improve clinical and commercial decision-making. The rollout marks a major step in applying domain-specific AI to real-world pharmaceutical challenges, from target identification to HCP engagement. SoundHound AI, Inc. (NASDAQ: SOUN) and Allina Health have launched"Alli," a conversational AI agent designed to improve the patient experience by automating key access points in the healthcare system. "Long wait times and administrative complexity can be a huge source of stress for patients," said Michael Anderson, Executive Vice President of Enterprise AI of SoundHound AI. "We are proud to partner with Allina Health on this important digital transformation. The organization is taking a forward-thinking approach by integrating AI to support patients with immediate, personalized assistance." Deployed inside Allina Health's Customer Experience Center, Alli connects directly with electronic medical records to authenticate callers and manage appointments. With 80% of calls now answered in under 45 seconds, the system has helped reduce wait times while freeing up staff for more complex patient needs. RadNet, Inc. (NASDAQ: RDNT) has acquired See-Mode Technologies, a company specializing in AI-powered ultrasound tools for thyroid and breast diagnostics. "Early deployment of See-Mode's FDA -approved thyroid ultrasound AI across a portion of our imaging centers has demonstrated up to a 30% reduction in scan time," said Dr. Howard Berger, President and Chief Executive Officer of RadNet. "The increase in capacity should improve our ability to drive better access and more revenue through RadNet's existing centers." The integration is expected to enhance operational capacity across RadNet's imaging centers and add value to its DeepHealth platform. With existing reimbursement pathways and a high annual volume of ultrasound exams, the acquisition is positioned to create new revenue opportunities and clinical efficiencies. Cigna Healthcare, a division of The Cigna Group (NYSE: CI), has rolled out a suite of AI-powered tools through its myCigna member portal to simplify key insurance tasks like finding care, checking benefits, and tracking costs. "Everyday moments in health care need to be easier," said Katya Andresen, Chief Digital and Analytics Officer of The Cigna Group. "These enhancements are a significant step in our journey to transform the experience and put customers at the heart of it." These enhancements include an AI virtual assistant, real-time cost tracking, personalized provider matching, and automated claim support. Early results show high user engagement and improved customer satisfaction, reinforcing Cigna's goal of making health coverage more intuitive and accessible. Source: need-to-know/ DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
